Acarbose has shown beneficial effects on hyperlipidemia caused by diabetes and decreases in free fatty acids and cholesterol levels (Patel, 2015), which result from the regulation of fatty acid binding protein and lecithin cholesterol acyltransferase according to Module B. Moreover, Hub Gene Analyses also showed a similar result to Module B, which further confirms the role of acarbose in blood lipids (Supplementary Table 2). This evidence concerns the gene LCAT and hyperlipidemia.